Daratumumab Market Analysis by Indication (Multiple Myeloma, AL Amyloidosis), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Treatment Setting (Monotherapy, Combination Therapy) and by Region: Global Forecast, 2024 - 2034

  • 2024-05-03
  • 241
  • Healthcare & Life Sciences

Market Overview

The Daratumumab market is predicted to develop at a compound annual growth rate (CAGR) of XX% from 2024 to 2034, when it is projected to reach USD XX Million, based on an average growth pattern. The market is estimated to reach a value of USD XX Million in 2024.


SOURCE: We Market Research

A monoclonal antibody called Daratumumab is used to treat the cancerous disease known as multiple myeloma. It helps destroy myeloma cells by targeting CD38, a protein present on their surface. Daratumumab either directly destroys cancer cells by attaching to CD38 or strengthens the immune system's defenses against them. It has demonstrated efficacy in enhancing patient outcomes and is frequently used in conjunction with other cancer therapy. Although Daratumumab selectively targets cancer cells while causing the least amount of damage to healthy organs, it represents a substantial development in the treatment of multiple myeloma and gives patients hope.

The Daratumumab market is driven by a number of important variables worldwide. The increasing global prevalence of multiple myeloma is driving up demand for targeted treatments such as Daratumumab.  Improvements in biotechnology, especially in the field of developing monoclonal antibodies, have made it possible to design more targeted and efficient therapeutic interventions. The market is also growing as a result of Daratumumab's extended approvals for diseases other than multiple myeloma, namely lymphoma and amyloidosis. Adoption of Daratumumab is further encouraged by strong clinical evidence demonstrating its safety and efficacy in multiple myeloma, particularly when used in combination treatments. Moreover, rising healthcare spending around the world promotes patient access to Daratumumab, which in turn promotes market sustainability and growth. 

Market Scope

Report Attributes


Market Size in 2024

USD XX Million

Market Forecast in 2034

USD XX Million

CAGR % 2024-2034


Base Year


Historic Data


Forecast Period


Report USP


Production, Consumption, company share, company heatmap, company production capacity, growth factors and more

Segments Covered

by Indication, by Distribution Channel, by Treatment Setting and By Region

Regional Scope

North America, Europe, APAC, South America and Middle East and Africa

Country Scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria


Daratumumab Industry: Dynamics & Restrains

Market opportunity:

We Market Research: Daratumumab Dashboard

Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.

Daratumumab Segmentation

Market- By Indication Analysis

By Indication, the Daratumumab Market is Categories into Multiple Myeloma, AL Amyloidosis. The Multiple Myeloma segment accounts for the largest share of around 68% in 2024.

Rising multiple myeloma incidence rates, Daratumumab's clinical efficacy, regulatory approvals for the drug's use in multiple myeloma, and the increasing need for efficient treatments to enhance patient outcomes and quality of life are the factors driving the global market for Daratumumab.

The following segments are part of an in-depth analysis of the global Daratumumab market:

Market Segments


By  Distribution Channel

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Pharmacies

By  End User

·         Hospitals & Clinics

·         Ambulatory Surgical Centers

·         Cancer Research Centers

By  Treatment Setting

·         Monotherapy

·         Combination Therapy


Daratumumab Industry: Regional Analysis

North America Market Forecast

North America dominate the Daratumumab Market with the highest revenue generating market with share of more than 48%. In North America the Daratumumab industry is driven by a robust healthcare infrastructure and the early uptake of novel medicines in the United States and Canada. The existence of significant pharmaceutical businesses dedicated to cancer therapies expedites the expansion of the industry.

Europe Market Statistics

Europe is the second largest region in Daratumumab Market. The growth of the Daratumumab market is driven by the rising incidence of multiple myeloma and the favorable reimbursement practices in Germany and France. Academic institutions and pharmaceutical corporations working together promote research and development, which drives the market.  

Asia Pacific Market Forecasts

Asia Pacific is expected to be the fastest-growing regional segment of the Daratumumab market during the forecast period. In the Asia Pacific region, the market for Daratumumab is being driven by rising awareness of cancer treatment choices as well as improved healthcare spending in China and Japan. The industry is growing as a result of major player’s investments to increase their market presence in developing nations like India.

Key Market Players 

The Daratumumab Market is dominated by a few large companies, such as

·         Janssen Pharmaceuticals

·         Other

1.      Global Daratumumab Market Introduction and Market Overview

1.1.    Objectives of the Study

1.2.    Global Daratumumab Market Scope and Market Estimation

1.2.1. Global Daratumumab Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)

1.2.2. Global Daratumumab Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034

1.3.    Market Segmentation

1.3.1. Indication of Global Daratumumab Market

1.3.2. Distribution Channel of Global Daratumumab Market

1.3.3. End User of Global Daratumumab Market

1.3.4. Treatment Setting of Global Daratumumab Market

1.3.5. Region of Global Daratumumab Market

2.      Executive Summary

2.1.    Global Daratumumab Market Industry Trends under COVID-19 Outbreak

2.1.1. Global COVID-19 Status Overview

2.1.2. Influence of COVID-19 Outbreak on Global Daratumumab Market Industry Development

2.2.    Market Dynamics

2.2.1. Drivers

2.2.2. Limitations

2.2.3. Opportunities

2.2.4. Impact Analysis of Drivers and Restraints

2.3.    Pricing Trends Analysis & Average Selling Prices (ASPs)

2.4.    Key Mergers & Acquisitions, Expansions, JVs, Funding / VCs, etc.

2.5.    Porter’s Five Forces Analysis

2.5.1. Bargaining Power of Suppliers

2.5.2. Bargaining Power of Buyers

2.5.3. Threat of Substitutes

2.5.4. Threat of New Entrants

2.5.5. Competitive Rivalry

2.6.    Value Chain / Ecosystem Analysis

2.7.    Russia-Ukraine War Impacts Analysis

2.8.    Economic Downturn Analysis

2.9.      Market Investment Opportunity Analysis (Top Investment Pockets), By Segments & By Region

3.      Global Daratumumab Market Estimates & Historical Trend Analysis (2019 - 2023)

4.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by INDICATION

4.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by INDICATION, 2019 to 2034

4.1.1. Multiple Myeloma

4.1.2. AL Amyloidosis

5.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by Distribution Channel

5.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel, 2019 to 2034

5.1.1. Hospital Pharmacies

5.1.2. Retail Pharmacies

5.1.3. Online Pharmacies

6.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by End-user

6.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034

6.1.1. Hospitals & Clinics

6.1.2. Ambulatory Surgical Centers

6.1.3. Cancer Research Centers

7.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by TREATMENT SETTING

7.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by End-user, 2019 to 2034

7.1.1. Monotherapy

7.1.2. Combination Therapy

8.      Global Daratumumab Market Estimates & Forecast Trend Analysis, by Region

8.1.    Global Daratumumab Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034

8.1.1. North America

8.1.2. Europe

8.1.3. Asia Pacific

8.1.4. Middle East & Africa

8.1.5. South America

9.      North America Daratumumab Market: Estimates & Forecast Trend Analysis

9.1.    North America Daratumumab Market Assessments & Key Findings

9.1.1. North America Daratumumab Market Introduction

9.1.2. North America Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)   By INDICATION   By Distribution Channel   By End-user   By TREATMENT SETTING   By Country     The U.S.     Canada     Mexico

10.  Europe Daratumumab Market: Estimates & Forecast Trend Analysis

10.1.  Europe Daratumumab Market Assessments & Key Findings

10.1.1.   Europe Daratumumab Market Introduction

10.1.2.   Europe Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By INDICATION    By Distribution Channel    By End-user    By TREATMENT SETTING    By Country Germany U.K. France Italy Spain Russia Rest of Europe

11.  Asia Pacific Daratumumab Market: Estimates & Forecast Trend Analysis

11.1.  Asia Pacific Market Assessments & Key Findings

11.1.1.   Asia Pacific Daratumumab Market Introduction

11.1.2.   Asia Pacific Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By INDICATION    By Distribution Channel    By End-user    By TREATMENT SETTING    By Country China Japan India Australia South Korea ASEAN Rest of Asia Pacific

12.  Middle East & Africa Daratumumab Market: Estimates & Forecast Trend Analysis

12.1.  Middle East & Africa Market Assessments & Key Findings

12.1.1.   Middle East & Africa Daratumumab Market Introduction

12.1.2.   Middle East & Africa Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By INDICATION    By Distribution Channel    By End-user    By TREATMENT SETTING    By Country U.A.E. Saudi Arabia Egypt South Africa Rest of Middle East & Africa

13.  South America Daratumumab Market: Estimates & Forecast Trend Analysis

13.1.  South America Market Assessments & Key Findings

13.1.1.   South America Daratumumab Market Introduction

13.1.2.   South America Daratumumab Market Size Estimates and Forecast (US$ Million) (2019 – 2034)    By INDICATION    By Distribution Channel    By End-user    By TREATMENT SETTING    By Country Brazil Argentina Colombia Rest of South America

14.  Competition Landscape

14.1.  Global Daratumumab Market Competition Matrix & Benchmarking, by Leading Players / Innovators / Emerging Players / New Entrants

14.2.  Global Daratumumab Market Competition White Space Analysis, By End-user

14.3.  Global Daratumumab Market Competition Heat Map Analysis, By End-user

14.4.  Global Daratumumab Market Concentration & Company Market Shares (%) Analysis, 2022

15.  Company Profiles

15.1.                     Janssen Pharmaceuticals

15.1.1.   .Company Overview & Key Stats

15.1.2.   Financial Performance & KPIs

15.1.3.   Product Portfolio

15.1.4.   Business Strategy & Recent Developments

* Similar details would be provided for all the players mentioned below 

15.2.      Others

16.  Research Methodology

16.1.  External Transportations / Databases

16.2.  Internal Proprietary Database

16.3.  Primary Research

16.4.  Secondary Research

16.5.  Assumptions

16.6.  Limitations

16.7.  Report FAQs

17.  Research Findings & Conclusion

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process

We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).


The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.

Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.

Frequently Asked Questions

What is the market size of Daratumumab Market in 2024?

Daratumumab Market was valued at USD XX Million in 2024.

What is the growth rate for the Daratumumab Market?

Daratumumab Market size will increase at approximate CAGR of XX% during the forecasted period.

Which are the top companies operating within the market?

Major companies operating within the Daratumumab Market is Janssen Pharmaceuticals and Other.

Which region dominates the Daratumumab Market?

North America dominates the market with an active share of 48%.


Select a license type that suits your business needs

Single User Access

US $3750

Only Three Thousand Seven Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4750

Only Four Thousand Seven Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5750

Only Five Thousand Seven Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI